Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged Gonadorelin Stimulation Test in Postoperative HH
NCT05184374Unknown
- Sponsor
- Huashan Hospital
- Start
- Jan 2022
- Primary completion
- Jun 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of gonadorelin in hypogonadotropic hypogonadism (HH), sponsored by Huashan Hospital. Primary endpoint: Level of luteinizing hormone, follicle stimulating hormone and testosterone at 1 month. Status: unknown.
02
Drugs
gonadorelin
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT05184374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05184374.